GlassScriptPrepare for your visit
David J Chalker
Family Medicine · York, PA · NPI 1497726293
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$7,780.45
in general payments reported to CMS, 2019-2025 · $626 in 2025
The $626 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Who reported paying
General payments only, top 6 by amount.
- Novo Nordisk INC $2,320.12
- Abbvie INC. $1,294.43
- Astrazeneca Pharmaceuticals LP $749.86
- Lilly USA, LLC $527.34
- Pfizer INC. $507.92
- Phathom Pharmaceuticals, INC. $408.86
Drugs and devices associated with these payments
Ozempic Rybelsus Vraylar Breztri Qulipta Voquezna Ubrelvy Nurtec Odt Airsupra Trelegy Ellipta Eliquis Mounjaro
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw David Chalker listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/294310/david-j-chalker